• Briefing 016/25: The NHS Pharmacy Contraception Service – What’s changing?

    This Community Pharmacy England Briefing provides guidance for community pharmacy owners and their teams who are already providing the Pharmacy Contraception Service on the changes to the service. CPE Briefing 016/25: Pharmacy Contraception Advanced Service – What’s changing? The post Briefing 016/25: The NHS Pharmacy Contraception Service – What’s changing? appeared first on Community Pharmacy

    Read more
  • August 2025 Price Concessions 5th Update

    The Department of Health and Social Care (DHSC) has today (29/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Nefopam 30mg tablets 90 £4.09 Olanzapine 10mg tablets 28 £4.99 Olanzapine 2.5mg tablets 28 £3.51 Olanzapine 20mg tablets 28 £4.99 Olanzapine 7.5mg tablets 28 £1.25 Propranolol 80mg modified-release capsules 28 £5.94 Repaglinide

    Read more
  • Ciclosporin eye drops and Winlevi® cream added to the Discount Not Deducted (DND) list

    Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 September 2025. This takes the total number

    Read more
  • Dydrogesterone 10mg tablets (Nalvee®) added to the HRT PPC medicines list

    From 1 September 2025,  Dydrogesterone 10mg tablets (Nalvee®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the September 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to reflect the

    Read more
  • 9 products re-classified as special containers from September 2025

    Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 September 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Simeticone 42mg/5ml oral drops Dentinox® Infant colic drops (Dendron Brands Ltd) 100 ml

    Read more
  • Adult Flu vacs service fee in 2025/26

    When the revised service specification for the 2025/26 Adult Flu Vaccination service was published last month, we informed pharmacy owners that the fee for this year was still under consideration by Ministers, following our submission of an evidence-based case for an increase in the fee. The decision has now been set out in the Drug

    Read more
  • August 2025 Price Concessions 4th Update

    The Department of Health and Social Care (DHSC) has today (28/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £51.02 Amiodarone 100mg tablets 28 £2.24 Amiodarone 200mg tablets 28 £4.82 Buprenorphine 2mg sublingual tablets sugar free 7 £1.83 Carbocisteine 250mg/5ml oral solution 300 £4.99 Co-amoxiclav

    Read more
  • August 2025 Price Concessions 3rd Update

    The Department of Health and Social Care (DHSC) has today (27/08/2025) confirmed the following list of price concessions for August 2025: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £31.95 Bumetanide 1mg tablets 28 £2.94 Buprenorphine 8mg sublingual tablets sugar free 7 £6.00 Co-codamol 30mg/500mg effervescent tablets 32 £2.40 Co-codamol 30mg/500mg effervescent

    Read more
  • Chief Executive’s Blog: Preparing for the future

    By Chief Executive Janet Morrison As the summer draws to a close, everyone in community pharmacy and the wider health service will be preparing, or perhaps more aptly bracing, themselves for what will undoubtedly be another frantic autumn and winter period. For community pharmacy, the announcement of the Community Pharmacy Contractual Framework (CPCF) arrangements for

    Read more
  • Update from our CEO: the next CPCF

    “While implementation of the 2025/26 CPCF continues at pace, our sights are also set on the future,” writes Community Pharmacy England Chief Executive Janet Morrison in a new blog. Despite the funding uplift earlier this year, pharmacy businesses remain in a financially precarious position. Janet explains that the views of pharmacy owners and their experiences

    Read more